Literature DB >> 6783094

Comparison of dipeptidyl peptidase IV prepared from pig liver and kidney.

K M Fukasawa, K Fukasawa, B Y Hiraoka, M Harada.   

Abstract

Dipeptidyl peptidase IV (dipeptidylpeptide hydrolase, EC 3.4.14.-) has been purified from the microsomal fraction of pig liver, using an immunoaffinity chromatography, and its properties compared with those of the enzyme purified from pig kidney. The amino acid compositions of both enzymes were similar. The same kinds of carbohydrates were found in both enzymes, but there were differences in the molar concentrations of individual sugars. The liver enzyme had greater concentrations of mannose, fucose and sialic acid than the kidney enzyme, while the concentrations of galactose and glucosamine were greater in the kidney enzyme. The carbohydrates accounted for approx. 18.3 and 22.7% of the weight of the kidney and liver enzymes, respectively. The pH optima, molecular weights, substrate specificities and Km values of the two enzymes and the effects of diisopropylfluorophosphate on their activities were nearly identical. The liver enzyme was heat- and pH-sensitive, but not attacked by proteinases.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6783094     DOI: 10.1016/0005-2744(81)90141-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Purification and Partial Characterization of a Prolyl-Dipeptidyl Aminopeptidase from Lactobacillus helveticus CNRZ 32.

Authors:  N M Khalid; E H Marth
Journal:  Appl Environ Microbiol       Date:  1990-02       Impact factor: 4.792

2.  Characterization of a soluble form of dipeptidyl peptidase IV from pig liver.

Authors:  K M Fukasawa; K Fukasawa; B Y Hiraoka; M Harada
Journal:  Experientia       Date:  1983-09-15

3.  Purification of dipeptidyl-aminopeptidase IV from human kidney by anti dipeptidyl-aminopeptidase IV affinity chromatography.

Authors:  T Hama; M Okada; K Kojima; T Kato; M Matsuyama; T Nagatsu
Journal:  Mol Cell Biochem       Date:  1982-03-05       Impact factor: 3.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.